In a record time of just 36 days a non-invasive BiPAP Ventilator 'SwasthVayu' has been developed by CSIR - National Aerospace Laboratories (NAL), Bangalore, a constituent of lab of CSIR to treat Covid-19 patients.
Dr Shekhar C Mande, DG CSIR said that CSIR NAL team has enabled a spin-off technology based on its expertise in the aerospace design domain.
The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre.
Jitendra J Jadhav, Director CSIR-NAL said the non-invasive ventilator will be ideal to treat moderate or mid-stage severe Covid-19 patients who do not require intubation and invasive ventilation.
"Based on